Pubblicazioni

Identification of predictive factors for overall survival at baseline and during azacitidine treatment in high-risk myelodysplastic syndrome patients treated in the clinical practice

2019 - ANNALS OF HEMATOLOGY

Scalzulli, Emilia; Molica, Matteo; ALUNNI FEGATELLI, Danilo; Colafigli, Gioia; Rizzo, Lorenzo; Mancini, Marco; Efficace, Fabio; Latagliata, Roberto; FoÃ &, Robin; Breccia, Massimo

Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia

2016 - EUROPEAN JOURNAL OF HAEMATOLOGY

Voso, Maria Teresa; Niscola, Pasquale; Piciocchi, Alfonso; Fianchi, Luana; Maurillo, Luca; Musto, Pellegrino; Pagano, Livio; Mansueto, Giovanna; Criscuolo, Marianna; ALOE SPIRITI, Maria Antonietta; Buccisano, Francesco; Venditti, Adriano; Tendas, Andrea; Piccioni, Anna Lina; Zini, Gina; Latagliata, Roberto; Filardi, Nunzio; Fragasso, Alberto; Fenu, Susanna; Breccia, Massimo